# Idroflog® for Treatment of Dry Eye Disease (IDROFLOG)

> **NCT05724056** · NA · UNKNOWN · sponsor: **Alfa Intes Industria Terapeutica Splendore s.r.l.** · enrollment: 130 (estimated)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DEVICE:** Idroflog®
- **DEVICE:** Sodium Hyaluronate 0.18% (Vismed®)

## Key facts

- **NCT ID:** NCT05724056
- **Lead sponsor:** Alfa Intes Industria Terapeutica Splendore s.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05724056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05724056, "Idroflog® for Treatment of Dry Eye Disease (IDROFLOG)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05724056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*